Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases

Hepato-Gastroenterology

Volumn 53, Issue 70, 2006, Pages 629-633

  Kosaka, Takeo ^a   Usami, Kazuo ^a   Ueshige, Nobuo ^a   Hasegawa, Taisuke ^a   Yoshitani, Shinichiro ^a   Sugaya, Junichi ^a   Nakano, Yasuharu ^a   Takashima, Shigeki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Lymphadenectomy; Paraaortic lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DEATH; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PARAAORTIC LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

AGED; AORTA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748647264     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. World Health Organization, International Agency for Research on Cancer: The global burden of cancer. In: Stewart BW, Kleihues P (Eds.). World cancer report. Lyon: IARC Press; 2003; pp. 12-9.
2. Hirai I, Murakami G, Kimura W, Tanuma K, Ito H: Origin of the thoracic duct and pancreaticoduodenal lymphatic pathways to the para-aortic lymph nodes. J Hepatobiliary Pancreat Surg 2001; 8:441-448.
3. Yamada K, Ohyama S, Ohta K, Matsubara T, Yamaguchi T, Muto T: Lymph node dissection of the para-aortic areas in gastric cancer operations around the aortic hiatus: Views during surgery and cadaveric dissection Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 2003; 36:443-450. (In Japanese with English abstract)
4. Sasaki J, Nashimoto A, Tutui H, et al: Indication of para-aortic lymph node dissection for gastric cancer. Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1989; 22:1749-1754. (In Japanese)
5. Yonemura Y, Miyazaki I: Surgical techniques and clinical significance of the radical lymph adenectomy against para-aortic lymph nodes in advanced gastric cancer. Rinsho Geka (Clinical Surgery) 1989; 44:777-784. (In Japanese)
6. Kouji K, Kakegawa T, Suematsu T, et al: Clinico-pathological study of the indication and significance for abdominal para-aortic lymph nodes dissection in advanced gastric cancer. J Jpn Soc Cancer Ther 1994; 29:957-963. (In Japanese with English abstract)
7. Kitamura M, Arai K, Iwasaki Y: Clinico-pathological studies and problems on para-aortic lymph node dissection - D4 dissection -. Nihon Geka Gakkaizasshi (Jpn J Surg) 1996; 97:302-307. (In Japanese with English abstract)
8. Yamamura Y, Kodera Y, Torii A, et al: Advantages and disadvantages of paraaortic lymph node dissection in surgical treatment for advanced gastric cancer. Nihon Rinshogekai Gakkaizasshi (Jpn J Clin Surgeons) 1996; 57:2891-2895. (In Japanese with English abstract)
9. Nakane Y, Okamura S, Masuya Y, Okumura S, Akehira K, Hioki K: Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45:1901-1906.
10. Baba M, Hokita S, Natsugoe S, et al: Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 2000; 47:893-896.
11. Suzuki H: Study for pars abdominalis aorta lymph node resection for total gastrectomy of progressive gastric cancer. Shyokakigeka (Gastroenterol Surg) 1990; 13:1597-607. (In Japanese)
12. Yonemura Y, Katayama K, Kamata T, et al: Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. Int Surg 1991; 76:222-225.
13. Kitamura Y, Suzuki H, Sasagawa T, Oguma H, Endou A, Ishizuka N: The effect of extended lymph node dissection in patients with gastric cancer from two aspects, quality of life and postoperative survival rate. Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1995; 28:927-931. (In Japanese with English abstract)
14. Kosaka T, Kiriyama M, Tomita F, Saito H, Takashima S, Nakano Y: A study of lymphadenectomy of para-aortic nodes for the gastric cancer. In: Nishi M, Sugano H, Takahashi T (Eds.). 1st International Gastric Cancer Congress. International Proceedings Division. Kyoto: Monduzzi Editore; 1995; pp. 1157-1160.
15. Sawai K, Hagiwara A, Yamaguchi T, Takahashi T: Total Gastrectomy with para-aortic lymph node dissection. Geka Chiryo (Surg Treatment) 1997; 76:599-604. (In Japanese)
16. Isozaki H, Okajima K, Fujii K, et al: Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 1999; 46:549-554.
17. Kunisaki C, Shimada H, Yamaoka H, et al: Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepatogastroenterology 2000; 47:586-589.
18. Gunji Y, Suzuki T, Kobayashi S, et al: Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer. Hepatogastroenterology 2003; 50:1178-1182.
19. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma, 13th Edition. Tokyo: Kanehara, 1999.
20. Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical oncology: Classification of regional lymph nodes in Japan. Int J Clin Oncol 2003; 8:248-275.
21. Ota K, Nishi M, Ohyama S, Ishihara S, Nakajima T: Advantages and disadvantages of para-aortic lymph node dissection for advanced gastric cancer. Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1995; 28:918-922. (In Japanese with English abstract)
22. Takahashi S, Tokuda H, Matsushige H, et al: Evaluation of D4 dissection for gastric cancer. Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1995; 28:932-926. (In Japanese with English abstract)
23. Uyama I, Ogiwara H, Takahara T, et al: Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer. J Surg Oncol 1996; 63:268-270.
24. Yamaoka H, Watarai S, Wakasugi J, Kunisaki C, Shimada H, Nishiyama K: The technique and significance of para-aortic lymphadenectomy for advanced gastric cancer with preservation of major and minor splanchnic nerves, celiac ganglions and superior mesenteric ganglion. Shujutu (Surgery) 1996; 50:457-466. (In Japanese)
25. Lewis WG, Edwards P, Barry JD, et al: D2 or not D2? The Gastrectomy question. Gastric Cancer 2002; 5:29-34.
26. Takeda J, Koufuji K, Kodama I, et al: Para-aortic lymph node dissection for the treatment of advanced gastric cancer. Kurume Med J 1993; 40:101-106.
27. Takahasbi S: Study of para-aortic lymph node metastasis of gastric cancer subjected to superextensive lymph node dissection. Nihon Geka Gakkaizasshi (Jpn J Surg) 1990; 91:29-35. (In Japanese with English abstract)
28. Nashimoto A, Sasaki J, Akai S: The study of lymphatic routes to the abdominal para-aortic lymph nodes and the significance of these lymph node dissection for advanced gastric cancer. Nihon Shyokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1991; 24:1169-1178. (In Japanese with English abstract)
29. Inada T, Ogata Y, Andoh J, et al: Significance of para-aortic lymph node dissection in patients with advanced and recurrent gastric cancer. Anticancer Res 1994; 14(2B):677-682.
30. Sano T, Sasako M, Yamamoto S, et al: Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767-2773.
31. Watanabe A, Yoriki R, Nakagawa M, et al: A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer. Gan To Kagaku Ryoho (Cancer & Chemotherapy) 2001; 28:1913-1916. (In Japanese with English abstract)
32. Itoh H, Bando E, Kawamura T, et al: A case of stage IV gastric carcinoma with lymph nodes metastases of the paraaorta responding markedly to TS-1. Gan To Kagaku Ryoho (Cancer & Chemotherapy) 2002; 29:2549-2553. (In Japanese with English abstract)
33. Nashimoto A, Yabusaki H, Tanaka O, Sasaki J, Akiyama N: Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a Phase II study with 5-fluorouracil, leucovorin, and cisplatin. Gastric Cancer 1999; 2:57-63.
34. Iwazawa T, Kinuta M, Yano H, et al: An oral anticancer drug, TS-1, enabled a patient with advanced gastric cancer with Virchow's metastasis to receive curative resection. Gastric Cancer 2002; 5:96-101.
35. Yoshikawa T, Tsuburaya A, Kobayashi O, et al: Neoadjuvant chemotherapy with a combination of irinotecan and cisplatin in advanced gastric cancer - a case report. Hepatogastroenterology 2000; 47:1575-1578.
36. Koyama M, Inaba Y, Watabe S, et al: A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1. Gan To Kagaku Ryoho (Cancer & Chemotherapy) 2003; 30:531-535. (In Japanese with English abstract)
37. Morifuji M, Murakami Y, Yokoyama T, et al: A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin. Gan To Kagaku Ryoho (Cancer & Chemotherapy) 2003; 30:711-715. (In Japanese with English abstract)
38. Hara A, Harada T, Tsunematu I, et al: A case of gastric carcinoma with metastasis in a paraaortic lymph node that responded to TS-1/CDDP combination therapy, in which the patient was able to undergo extirpation with grade B curability. Gan To Kagaku Ryoho (Cancer & Chemotherapy) 2002; 29:1427-1430. (In Japanese with English abstract)